Ketamine Terminated Phase 2 Trials for Sickle Cell Disorders Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00595530Low-Dose Ketamine Infusion for Children With Sickle Cell Disease-Related Pain